(Q35328194)

English

Functional characterization of epithelial ovarian cancer histotypes by drug target based protein signaling activation mapping: implications for personalized cancer therapy

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

Functional characterization of epithelial ovarian cancer histotypes by drug target based protein signaling activation mapping: implications for personalized cancer therapy (English)

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

1 reference

based on heuristic

inferred from title

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25311472%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

Antonella Ravaggi

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25311472%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25311472%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

Roberto Angioli

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25311472%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

Lance A. Liotta

14

object named as

Lance A Liotta

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25311472%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

author name string

Maria Isabella Sereni

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25311472%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

Elisa Baldelli

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25311472%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

Guido Gambara

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25311472%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

Jianghong Deng

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25311472%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

Elisabetta Bandiera

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25311472%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

Eliana Bignotti

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25311472%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

Monica Ragnoli

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25311472%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

Germana Tognon

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25311472%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

Francesco Meani

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25311472%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

Sergio L Pecorelli

15

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25311472%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

Emanuel Petricoin

16

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25311472%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

Mariaelena Pierobon

17

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25311472%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

publication date

1 January 2015

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25311472%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

15

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25311472%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

2-3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25311472%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

365-373

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25311472%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201400214

21 January 2018

Rethinking ovarian cancer: recommendations for improving outcomes

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201400214

21 January 2018

Current standards of care for chemotherapy of optimally cytoreduced advanced epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201400214

21 January 2018

Incorporation of anti-angiogenesis therapy in the management of advanced ovarian carcinoma--mechanistics, review of phase III randomized clinical trials, and regulatory implications

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201400214

21 January 2018

PARP inhibitors in ovarian cancer: current status and future promise

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201400214

21 January 2018

Hormone-receptor expression and ovarian cancer survival: an Ovarian Tumor Tissue Analysis consortium study

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201400214

21 January 2018

ARID1A mutations in endometriosis-associated ovarian carcinomas

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201400214

21 January 2018

Randomized phase III study of erlotinib versus observation in patients with no evidence of disease progression after first-line platin-based chemotherapy for ovarian carcinoma: a European Organisation for Research and Treatment of Cancer-Gynaecologi

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201400214

21 January 2018

Tissue is alive: New technologies are needed to address the problems of protein biomarker pre-analytical variability

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201400214

21 January 2018

A portrait of tissue phosphoprotein stability in the clinical tissue procurement process

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201400214

21 January 2018

Multiplexed cell signaling analysis of human breast cancer applications for personalized therapy

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201400214

21 January 2018

HER2 aberrations in cancer: implications for therapy

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201400214

21 January 2018

Phase II Trial of Cetuximab and Conformal Radiotherapy Only in Locally Advanced Pancreatic Cancer with Concurrent Tissue Sampling Feasibility Study

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201400214

21 January 2018

Comparison of global versus epidermal growth factor receptor pathway profiling for prediction of lapatinib sensitivity in bladder cancer

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201400214

21 January 2018

The needle in the haystack: application of breast fine-needle aspirate samples to quantitative protein microarray technology

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201400214

21 January 2018

A functional proteogenomic analysis of endometrioid and clear cell carcinomas using reverse phase protein array and mutation analysis: protein expression is histotype-specific and loss of ARID1A/BAF250a is associated with AKT phosphorylation

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201400214

21 January 2018

Functional genomics identifies five distinct molecular subtypes with clinical relevance and pathways for growth control in epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201400214

21 January 2018

Identification of novel therapeutic targets in microdissected clear cell ovarian cancers

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201400214

21 January 2018

Integrated genomic analyses of ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201400214

21 January 2018

Expression of stem cell and epithelial-mesenchymal transition markers in primary breast cancer patients with circulating tumor cells

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201400214

21 January 2018

Prognostic determinants in patients with uterine and ovarian clear cell carcinoma: a SEER analysis

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201400214

21 January 2018

Clear cell carcinoma of the ovary: a review of the literature

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201400214

21 January 2018

Epidermal growth factor receptor expression in normal ovarian epithelium and ovarian cancer. I. Correlation of receptor expression with prognostic factors in patients with ovarian cancer.

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201400214

21 January 2018

Epidermal growth factor, oestrogen and progesterone receptor expression in primary ovarian cancer: correlation with clinical outcome and response to chemotherapy.

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201400214

21 January 2018

Dual faces of SH2-containing protein-tyrosine phosphatase Shp2/PTPN11 in tumorigenesis

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201400214

21 January 2018

Role of protein tyrosine phosphatases in the modulation of insulin signaling and their implication in the pathogenesis of obesity-linked insulin resistance

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201400214

21 January 2018

Body size and risk of epithelial ovarian and related cancers: a population-based case-control study

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201400214

21 January 2018

Protein pathway biomarker analysis of human cancer reveals requirement for upfront cellular-enrichment processing.

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201400214

21 January 2018

Glioblastoma cell enrichment is critical for analysis of phosphorylated drug targets and proteomic-genomic correlations

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201400214

21 January 2018

Molecular analysis of HER2 signaling in human breast cancer by functional protein pathway activation mapping

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201400214

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35328194&oldid=2145262114"